Eli Lilly and Co

Johnson & Johnson

Merck & Co Inc

Roche Holding AG

AstraZeneca PLC

Novartis AG

Pfizer Inc

Sanofi SA

Bristol-Myers Squibb Co

Zoetis Inc

GSK plc

Merck KGaA

Novo Nordisk A/S

Jiangsu Hengrui Pharmaceuticals Co Ltd

Ucb SA

Bayer AG

Sun Pharmaceutical Industries Ltd

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Hansoh Pharmaceutical Group Company Ltd

Viatris Inc

Pharmsynthez PJSC engages in the research, development, manufacture, and distribution of pharmaceuticals. The firm focuses on the medical research, development and manufacture of drugs ingredients used in oncology, gynecology, tuberculosis therapy and others. In addition, Farmsintez OAO offers chemical research services, chemical technology development and quality control services. The firm sells its products domestically, as well as abroad, including the Commonwealth of Independence State (CIS) countries. The company has two wholly owned subsidiaries located in Moscow and Tallin, Estonia. As of May 21, 2011, the Company’s major shareholder was EphaG AS with a stake of 69.23%. In April 2013, the Company acquired the pharmacies of Guardum Pharmaceuticals in the U.S. state of Florida.

Компания Фармсинтез, быстроразвивающаяся инновационная фармацевтическая компания, основанная в 1996 году.
Фармсинтез – первая российская биофармацевтическая компания, вышедшая в 2010 году на публичный рынок акций.

Уникальная специализация на производстве и продвижении портфеля инновационных лекарственных препаратов, а также возможность осуществления контрактного R&D качественно выделяют Фармсинтез среди немногих российских биофармацевтических производителей.



Farmsynthez

Return on assets ROA

What is ROA ?

What is ROA of Farmsynthez ?